Bruker Corporation (Bruker) (NASDAQ: BRKR), a leading global provider
of high-performance scientific instruments, and Bruker Energy & Supercon
Technologies, Inc. (BEST), a leading provider of superconducting
technology and enabling tools and a Bruker subsidiary, today announced
that BEST has filed a Form S-1 Registration Statement with the United
States Securities and Exchange Commission relating to the proposed
initial public offering (the offering) of common stock of BEST. The
offering may include shares offered by Bruker as a selling stockholder.
The number of shares to be offered by BEST and by Bruker and the price
range for the offering have not yet been determined. Bruker intends to
retain a controlling equity interest in BEST for the foreseeable future.
A registration statement relating to the common stock to be sold in the
offering has been filed with the Securities and Exchange Commission but
has not yet become effective. These securities may not be sold nor any
offers to buy be accepted prior to the time the registration statement
becomes effective. This news release shall not constitute an offer to
sell or the solicitation of an offer to buy, nor shall there be any sale
of these securities in any state in which such an offer, solicitation or
sale would be unlawful prior to registration or qualification under the
securities laws of any such state.
Jefferies & Company, Inc. and UBS Investment Bank are acting as joint
book-running managers for the offering. Needham & Company, LLC is acting
as lead manager and Gleacher & Company Securities, Inc. is acting as
co-manager for the offering.
The offering is only being made by means of a prospectus. When
available, copies of the preliminary prospectus may be obtained by
contacting: Jefferies & Company, Inc., 520 Madison Avenue, New York, NY
10022, Attention: Syndicate Prospectus Department, (888) 449-2342; and
UBS Investment Bank, 299 Park Avenue, New York, NY 10171, Attention:
Prospectus Department, (888) 827-7275.
This release contains forward-looking statements as defined under the
U.S. federal securities laws including, but not limited to, statements
regarding BESTs intention to conduct an offering of its common stock
and that Bruker may sell a portion of its BEST shares in the offering.
Actual events could differ materially from those anticipated in the
forward-looking statements as a result of certain factors, including but
not limited to adverse changes in general economic or market conditions,
the inability to manage successfully and complete the offering, the risk
that the offering of BEST may not occur in its expected timeframe or at
all, and other important factors disclosed previously and from time to
time in Brukers filings with the U.S. Securities and Exchange
Commission. Bruker disclaims any obligation to update any such
forward-looking statements after the date of this release.
Source: Business Wire
